Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
12.65
+0.23 (1.85%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $763.69 million as of April 17, 2025. Its market cap has decreased by -39.05% in one year.
Market Cap
763.69M
Enterprise Value
160.60M
1-Year Change
-39.05%
Ranking
Category
Stock Price
$12.65
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $763.69M, an increase of 583.70%. That is a compound annual growth rate of 23.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 763.70M | -36.21% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 746.33B |
| UnitedHealth Group | 426.33B |
| Johnson & Johnson | 378.35B |
| AbbVie | 306.12B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 226.26B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |